We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$20.1B
AUM Growth
+$2.23B
Cap. Flow
+$1.48B
Cap. Flow %
7.34%
Top 10 Hldgs %
40.12%
Holding
3,238
New
604
Increased
1,013
Reduced
977
Closed
628

Sector Composition

Rank Sector Weight
1 Financials 0.72%
2 Technology 0.56%
3 Consumer Discretionary 0.49%
4 Healthcare 0.48%
5 Consumer Staples 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AREX
2551
DELISTED
Approach Resources Inc.
AREX
$25K ﹤0.01%
10,160
-10,348
-50% -$27.7K
MBRX icon
2552
Moleculin Biotech
MBRX
$9.61M
$24K ﹤0.01%
+6
New +$24.6K
SGYP
2553
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$24K ﹤0.01%
+13,760
New +$23.8K
ATHE
2554
Alterity Therapeutics
ATHE
$80.5M
$22K ﹤0.01%
+1,172
New +$23.3K
CARM
2555
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
+573
New +$25.2K
ITP icon
2556
IT Tech Packaging
ITP
$2.86M
$22K ﹤0.01%
+2,195
New +$24.8K
VIVS
2557
VivoSim Labs
VIVS
$1.21M
$22K ﹤0.01%
+65
New +$21.4K
CLRB icon
2558
Cellectar Biosciences
CLRB
$19.8M
$20K ﹤0.01%
11
-1
-8% -$3.07K
NURO
2559
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$20K ﹤0.01%
+189
New +$20.8K
OTLK icon
2560
Outlook Therapeutics
OTLK
$187M
$19K ﹤0.01%
143
-1
-0.7% -$147
GSV
2561
DELISTED
Gold Standard Ventures Corp.
GSV
$19K ﹤0.01%
13,870
-15,278
-52% -$23.4K
CBK
2562
DELISTED
Christopher & Banks Corporation
CBK
$19K ﹤0.01%
+20,508
New +$20.6K
ARC
2563
DELISTED
ARC Document Solutions, Inc.
ARC
$19K ﹤0.01%
10,523
-1,045
-9% -$2.18K
MARA icon
2564
Marathon Digital Holdings
MARA
$3.83B
$17K ﹤0.01%
+4,702
New +$25.4K
PXS icon
2565
Pyxis Tankers
PXS
$47M
$16K ﹤0.01%
+3,796
New +$17.3K
RSYS
2566
DELISTED
Radisys Corp
RSYS
$16K ﹤0.01%
+23,510
New +$17K
FCEL icon
2567
FuelCell Energy
FCEL
$1.45B
$15K ﹤0.01%
+31
New +$20.4K
MYSZ icon
2568
My Size
MYSZ
$1.98M
$15K ﹤0.01%
6
+1
+20% +$3.49K
BIOL
2569
DELISTED
Biolase, Inc.
BIOL
$15K ﹤0.01%
+5
New +$18.8K
TOVX icon
2570
Theriva Biologics
TOVX
$10.1M
$14K ﹤0.01%
7
+4
+133% +$9.18K
AYTU icon
2571
AYTU BioPharma
AYTU
$22.3M
$13K ﹤0.01%
+13
New +$21.7K
DCOY
2572
Decoy Therapeutics
DCOY
$2.14M
0
BAC.WS.B
2573
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$13K ﹤0.01%
+20,535
New +$31.7K
CEI
2574
DELISTED
Camber Energy, Inc
CEI
0
BLIN icon
2575
Bridgeline Digital
BLIN
$14.5M
$12K ﹤0.01%
+202
New +$15.7K

Similar funds

Two Sigma Securities's Q2 2018 Portfolio in Review

As of Q2 2018, Two Sigma Securities held 3,238 positions worth $20.1B, up 13% from $17.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Two Sigma Securities deployed $1.48B of net new capital in Q2 2018, opening 604 new positions and adding to 1,013 existing holdings. Its largest new stake was JPMorgan Chase: 141,481 shares worth $14.7M.

By sector, the portfolio is most concentrated in Financials at 0.72% of assets, down from 0.77% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $14.2M trimmed.

  • Two Sigma Securities's largest Q2 2018 buy was JPMorgan Chase: 141,481 shares worth $14.7M.
  • Two Sigma Securities added most to iShares Russell 2000 ETF in Q2 2018, an estimated $52.4M increase.
  • Two Sigma Securities's biggest Q2 2018 reduction was Microsoft, cutting an estimated $14.2M.
  • Two Sigma Securities fully exited iShares Core S&P 500 ETF in Q2 2018, selling an estimated $18.9M.
  • Two Sigma Securities's ten largest holdings make up 40% of its $20.1B portfolio in Q2 2018.
  • Two Sigma Securities opened 604 new positions and closed 628 in Q2 2018.
  • Two Sigma Securities's portfolio value rose 13% quarter-over-quarter to $20.1B.

Based on Two Sigma Securities's 13F filing for Q2 2018, filed 14 Aug 2018.